Format

Send to

Choose Destination
Dtsch Med Wochenschr. 2019 Oct;144(20):1417-1422. doi: 10.1055/a-0867-5426. Epub 2019 Oct 8.

[Update ESC-Guideline: Myocardial Revascularization].

[Article in German; Abstract available in German from the publisher]

Author information

1
Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universität, Düsseldorf.
2
Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg · Bad Krozingen, Bad Krozingen.

Abstract

in English, German

This article gives an overview of the novelties of the current ESC-guideline on "myocardial revascularization (2018)". Twenty completely new recommendations were given (seven class I, five class IIa, six class IIb and two class III). Moreover, four recommendations were upgraded and six downgraded. The comprehensive changes relate to preprocedural (diagnosis, choice of revacularisation-strategy), intraprocedural (revascularisation) and postprocedural aspects.

PMID:
31594016
DOI:
10.1055/a-0867-5426

Conflict of interest statement

F.-J. Neumann berichtet, dass sein Arbeitgeber Forschungsunterstützung sowie Berater- und Vortragshonorare von Daiichi Sankyo, Astra Zeneca, Sanofi-Aventis, Bayer, The Medicines Company, Bristol, Novartis, Roche, Boston Scientific, Biotronik, Medtronic, Edwards und Ferrer erhalten hat.Die übrigen Autoren geben an, dass keine Interessenkonflikte bestehen.

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center